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Background: Factual data exploring the relationship between obesity and diabetes mellitus prevalence from
rural areas of sub-Saharan Africa remain scattered and are unreliable. To address this scarceness, this work reports
population study data describing the relationship between the obesity and the diabetes mellitus in the general
population of the rural area of Katana (South Kivu in the Democratic Republic of the Congo).
Methods: A cohort of three thousand, nine hundred, and sixty-two (3962) adults (>15 years old) were followed
between 2012 and 2015 (or 4105 person-years during the observation period), and data were collected using the
locally adjusted World Health Organization’s (WHO) STEPwise approach to Surveillance (STEPS) methodology. The
hazard ratio for progression of obesity was calculated. The association between diabetes mellitus and obesity was
analyzed with logistic regression.
Results: The diabetes mellitus prevalence was 2.8 % versus 3.5 % for obese participants and 7.2 % for those with
metabolic syndrome, respectively. Within the diabetes group, 26.9 % had above-normal waist circumference and
only 9.8 % were obese. During the median follow-up period of 2 years, the incidence of obesity was 535/100,000
person-years. During the follow-up, the prevalence of abdominal obesity significantly increased by 23 % (p <0.0001),
whereas the increased prevalence of general obesity (7.8 %) was not significant (p = 0.53). Finally, diabetes mellitus
was independently associated with age, waist circumference, and blood pressure but not body mass index.
Conclusion: This study confirms an association between diabetes mellitus and abdominal obesity but not with
general obesity. On the other hand, the rapid increase in abdominal obesity prevalence in this rural area population
within the follow-up period calls for the urgent promoting of preventive lifestyle measures.
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Diabetes mellitus (DM) is nowadays known as a major
public health problem worldwide because of its continu-
ously increasing prevalence and the risk of associated
cardiovascular and renal diseases. Indeed, 382 million
people were estimated to have DM in 2013; the number
of people with DM is predicted to reach 592 million by
2035 [1]. In contrast, this disease affected only 30 and
157 million people in 1985 and 2000, respectively [2].
According to data from occidental settings and most
developed areas in low- and middle- income countries,
the increase of diabetic patient’s number is mainly due
to the increasing figures of obese people and aging of
the general population [3–5].
The association between DM and obesity with or with-
out other cardiovascular risk factors is known as the
‘diabesity’ [6]. It also has an insulin resistance pattern,
which is clinically determined by the criteria of the
metabolic syndrome (MS) [7].
The prevalence of ‘diabesity’ is rapidly increasing in
Africa following the worldwide trend [8, 9]. This progress
has been largely linked to changes in lifestyles of the in-
habitants, especially those living in urban areas [8–10].
However, in rural Africa, the context is quite different be-
cause no substantial changes are seen. Field and manual
work (agricultural, rural daily activities, etc.) are active,
physical exercises that may contribute to the reduced
prevalence of obesity. However, it is not well-documented
whether this assumed low prevalence of obesity in rural
areas matches with DM prevalence.
Furthermore, in the sub-Saharan African setting the
DM characteristic is specific. Considered atypical, it is
mainly described with a low frequency of insulin resist-
ance [11–13]. Based on the current scarce data, it is
even speculated that the frequency of atypical diabetes
would be more important in rural areas [10].
In the Democratic Republic of the Congo (DRC), data
on “diabesity” in rural areas are very rare and screening
for the disease in this area is very low [10].
In 2012, an observatory to monitor the development of
non-communicable diseases and risk factors, including ar-
terial hypertension (AHT) and DM, was established in
South Kivu in eastern DRC. The ultimate goal of this ob-
servatory is to implement control strategies against these
risk factors [14].
The present work presents the partial results about
the relationship between DM and obesity from one site
of the cohort study.
Methods
Study population
An observatory center that continuously monitors and
collects factual data regarding the prevalence of non-
communicable diseases including DM, AHT, and othercardiovascular risk factors has been established at the
Catholic University of Bukavu Medical School in collab-
oration with Ghent University in Belgium (Bukavu
ObServ Study).
The rural survey was conducted in the village of Ciranga
[estimated 8765 inhabitants] in Katana, a rural zone
45 km from Bukavu. All adult subjects of both genders
aged 15 years or older (approximately 50 % of the popula-
tion) and living in the site were asked to participate. Their
verbal informed consent was obtained. At the end of the
first cycle of the survey (2012–2013), 1601 households in
rural areas were visited and 4345 adults were found. A
total of 108 (2.4 %) subjects declined to participate in the
study. The acceptance rate was 97.6 %.
In 2015 (end of the second cycle), 3962 subjects were
found. Of these cases, 2088 were old cases (49.2 %) in-
cluding 26 deaths and 1874 were newly recruited. These
constitute the 3936 participants of the study.
Data collection
Baseline examination (2012)
Data collection was based on a systematic sampling
method and included all residents in a selected adminis-
trative area at the time of data collection.
Teams of trained investigators visited the participants
at their home and collected data using a standardized
questionnaire and physical measurements.
The questionnaire used was adapted from the World
Health Organization’s STEP (WHO-STEP) questionnaire
for the local context [15]. It included questions on
individual data, family history, lifestyle habits such as
smoking and alcohol, weekly physical activity, dietary
habits, medical history of the subjects, the notion of
cardiovascular risk factors, and management of chronic
medications.
Then, body weight was measured to the nearest 100 gr
while the subject was dressed only in light-weight cloth-
ing using an electronic scale (Tanita Digital Bathroom
Scale HD-325®); height was determined with a SECA
mesband 206 cm® and with a tape measure; waist
circumference (WC) was measured between the 12th rib
to the iliac crest at the end of expiration to nearest 0.5
centimeter.
Finally, blood pressure and pulse rate were determined
using an electronic device (OMRON Hem 7001E®)
These measurements were taken on the right arm, which
was supported at heart level, after the subject had been
seated and relaxed for at least 5 min.
The average of three consecutive measurements was
used for analysis. Sphygmomanometers were calibrated
monthly with a mercury device and any difference of
4 mmHg or more disqualified use of the device. Bedridden
persons and/or those with edematous syndrome and preg-
nant women were excluded from the measurements.
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Because in the selected area there is no reliable and
continuous census data available, the Bukavu ObServ
study included yearly census-like surveys, known as the
Demographic Surveillance System (DSS). The goal of
those surveys is to monitor the demographic dynamics
of the study population and to document all changes in
the denominator figures used for incidence and preva-
lence calculations. This survey was done each year (since
2012–the baseline) and is based on a short questionnaire
that asks questions about the household baseline
composition and in-and-out dynamics (i.e., births, immi-
grations, emigrations, and deaths). The questionnaire
included also questions related to socio-economic com-
ponents and their changes over time.
Follow-up data collection
In 2015, investigators revisited all households in the
same administrative areas that were visited during the
baseline survey and re-examined the present subjects
using the same methodology as in baseline surveys. For
this 2015 phase, anthropometric parameters (weight,
height, waist circumference, and neck circumference)
were taken under the same conditions as in baseline
surveys.
Then, capillary blood from a finger puncture was
immediately analyzed for glucose concentration by the
glucose oxidase method using a portable electronic
blood glucose monitor (Codefree®) with commercially
available strips. This method was previously calibrated in
a hospital setting with a laboratory-based method.
When fasting glucose (last meal > 8 h) or postpran-
dial blood glucose (last meal <8 h) were ≥ 126 mg/dl
and ≥ 140 mg/dl, respectively, a fasting control test
was performed the next day.
Finally, 4 mL of blood were obtained from an antecubi-
tal venopuncture for lipid, creatinine, and uric acid deter-
minations by standard methods of spectrophotometry.
Similarly, qualitative proteinuria by dipstick was assessed.
Study outcomes
DM was defined as fasting glucose ≥ 126 mg/dl and/or
taking hypoglycemic medication; prediabetes was defined
as a fasting glucose between 100 and 125 mg/dl. High
blood pressure was defined as systolic blood pressure
(SBP) ≥ 140 mmHg and/or diastolic blood pressure
(DBP) ≥ 90 mmHg and/or taking antihypertensive me-
dications [16]. Body mass index (BMI) scores less than
18.5 kg/m2, between 18.5 and 24.9 kg/m2, between 25 and
29.9 kg/m2 and ≥ 30 kg/m2 were defined as malnourished,
normal weight, overweight, and obese, respectively [17].
Abdominal obesity was defined by a WC ≥ 94 cm for both
men and women. WC ≥ 94 cm provided the same rate of
abdominal obesity as reported in our previous study [18]and in other studies [19, 20]. MS has been defined as the
presence of three or more of the following five risk factors:
1) abdominal obesity (WC ≥ 95 cm in men and in
women); 2) hypertriglyceridemia (triglycerides (TG) ≥
150 mg/dL or use of medications to lower triglycerides);
3) decreased high-density lipoprotein cholesterol HDL-C
(<40 mg/dL in men and <50 mg/dL in women or use of
medication to increase HDL-C); 4) high blood pressure
(systolic blood pressure ≥130 mmHg and/or diastolic
blood pressure ≥85 mmHg and/or use of antihypertensive
medication); 5) high fasting plasma glucose ≥100 mg/dL
or use of hypoglycemic medication. Intense professional
activity was work which required a significant increase in
breathing and heart rate. High intensity leisure activities
such as sports were categorized as “intense activity”. A
moderate usual physical activity such as walking for at
least 10 min or displacement by bicycle was categorized as
“moderate activity”.
Statistical analysis
The software Epi-Info® 2008 version 3.5.1 (Centers for
Disease Control and Prevention, Atlanta, GA, USA) and
MedCalc® Version V12.4.0 (MedCalc Software, Ostend,
Belgium) were used for statistical analysis. Data are pre-
sented as appropriate, by the median (interquartile range)
or the relative frequency in percent. The incidence of
obesity in each group was estimated using the Kaplan–
Meier product-limit estimator, and groups were compared
using the log-rank test. The rate of progression to obesity
was calculated in each group by dividing the number of
individuals with obesity by the number of person-years of
observation. Hazard ratios and 95 % confidence intervals
(CIs) for progression to obesity were analyzed using the
Cox proportional hazards model.
The occurrence of DM and MS according to candidate
risk factors was studied by multiple logistic regressions.
A probability (p) <0.05 was considered statistically
significant.
Results
General characteristics of the study population
Table 1 shows the general characteristics of the study
population. Of the 3936 subjects, 2213 (56.2 %) were
female and 1723 (43.7 %) were men.
In the entire study population at the end of the second
cycle, the median interquartile range (IQR) age, BMI,
and WC were 34.0 (22.0 to 50.0) years, 22.2 (20.5 to
24.1) kg/m2, and 79.0 (74.0 to 85.0) cm, respectively. In
the cohort, 77 % had a moderate habitual physical
activity, 15.3 % participated in an intense habitual phys-
ical activity, and 50.2 % an intense professional activity.
Only 7.7 % of the study population was inactive.
Compared to the subgroup of subjects with normal
weight, subgroups of obese and malnourished patients
Table 1 General characteristics of the study population
Total group
n = 3.962 (100 %)
malnourished
n = 269 (6.8 %)
Normal weight
n = 3.003 (75.8 %)
Overweight
n = 551 (13.9 %)
Obese
n = 139 (3.5 %)
p
Age (years) 34.0 (22.0 to 50.0) 39.5 (20.0 to 63.5) 32.0 (22.0 to 48.0) 36.0 (25.0 to 45.0) 43.0 (31.0 to 52.0) <0.0001
BMI (kg/m2) 22.2 (20.5 to 24.1) 17.7 (17.0 to 18.1) 21.8 (20.5 to 23.1) 26.4 (25.6 to 27.6) 32.3 (31.1 to 34.3) <0.0001
WC (cm) 79.0 (74.0 to 85.0) 71.0 (68.0 to 76.0) 78.0 (74.0 to 82.0) 90.0 (82.0 to 96.0) 102.0 (96.0 to 110.0) <0.0001
SBP (mmHg) 113.6 (104.3 to 125.3) 110.3 (101.0 o to 124.0) 113.5 (104.3 to 124.5) 115.0 (105.4 to 127.2) 118.0 (107.3 to 132.2) 0.0001
DBP (mmHg) 73.5 (67.0 to 81.0) 72.0 (65.3 to 79.0) 73.0 (67.0 to 80.0) 75.1 (69.0 to 84.1) 79.4 (72.2 to 87.3) <0.0001
Pulse rate (beats/min) 75.6 (68.6 to 84.0) 79.0 (69.0 to 86.0) 75.3 (68.3 to 83.6) 76.0 (69.3 to 84.0) 78.0 (71.3 to 85.8) 0.005
Glycaemia (mg/dl) 96.0 (85.0 to 105.0) 96.0 (86.0 to 108.0) 94.5 (84.0 to 104.0) 98.0 (88.0 to 107.0) 100.0 (92.0 to 112.0) <0.0001
TC (mg/dl) 152.0 (138.0 to 170.0) 151.5 (138.0 to 166.5) 150.0 (136.0 to 169.0) 154.5 (138.0 to 178.5) 161.5 (145.0 to 187.5) 0.0001
HDL-c (mg/dl) 42.0 (38.0 to 48.0) 42.0 (37.0 to 47.0) 42.0 (38.0 to 47.0) 42.0 (38.0 to 49.0) 44.0 (40.0 to 50.0) 0.006
LDL-c (mg/dl) 91.0 (76.0 to 106.0) 93.0 (75.0 to 105.0) 90.0 (76.0 to 105.0) 93.0 (77.0 to 109.0) 93.0 (82.0 to 114.0) 0.002
TG (mg/dl) 98.0 (74.0 to 124.0) 93.5 (72.5 to 126.5) 96.0 (74.0 to 123.0) 99.5 (76.5 to 124.5) 109.5 (76.5 to 136.5) 0.03
Usual physical activity
None 7.7 8.0 7.2 9.6 10.1 0.03
Moderate 77.2 73.9 76.7 79.1 82.6
Intense 15.1 18.2 16.1 11.3 7.2
Intense professional activity
Yes 49.8 41.6 51.4 48.2 34.2 0.01
Instruction level
Illiterate/primary 56.4 48.2 56.2 61.7 50.7 0.01
Secondary 41.7 50.2 41.7 36.7 47.8
University 1.9 1.1 2.1 1.7 1.4
BMI body mass index, WCwaist circumference, SBP systolic blood pressure, DBP diastolic blood pressure, TC total cholesterol, HDL-C high density lipoprotein
cholesterol, LDL-C low density lipoprotein cholesterol, TG triglycerides
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(p <0.001). However, WC, SBP, DBP, Total cholesterol
(TC), low-density lipoprotein cholesterol (LDL-C), and
TG significantly increased with BMI (p <0.05). Finally, the
level of physical activity was inversely correlated with BMI
(p <0.05).
Dynamic between body mass index and waist
circumference
Trends between BMI and WC of the 2062 included sub-
jects since the beginning of the study are noted in Table 2.
During the follow-up period (median = 2 years), BMI and
WC significantly increased by +0.6 kg/m2 and +2.0 cm,
respectively. Similarly, the prevalence of overweight indi-
viduals and abdominal obesity significantly increased by
23 % (from 11.0 to 14.3 %) and 42.8 % (from 7 to 10.0 %)
(p <0.0001), respectively. Conversely, the increased preva-
lence of general obesity (BMI > 30Kg/m2) of 7.8 % (3.8 to
4 %) was not significant (p = 0.53).
Impact of obesity
Table 3 shows the hazard ratio for the incidence of obes-
ity. During the 4105 person-years observation period,
the incidence of obesity was 535/100,000 person-year.The incidence of obesity was significantly higher in
subjects between the ages of 40 and 59 (1028/100,000
person-years) compared to subjects <40 years (374/
100,000 person-years) and subjects ≥ 60 years (279/
100,000 person-years) (p <0.0001).
Diabetes mellitus and obesity
Table 4 shows the odds ratio of diabetes mellitus by
supposed risk factors. In the overall study population,
the prevalence of diabetes mellitus was 2.8 %. Among
diabetics, only 9.8 % were obese and 26.9 % had a large
WC. In the overall study population, the prevalence of
DM increased with WC from 1.6 % in the subgroup in
the first WC tertile to 4.0 % in the subgroup of the
third WC tertile (p = 0.003). The prevalence of DM
described a U-shaped curve in terms of BMI with low
prevalence in the subgroup with normal weight
(2.1 %) and a relatively high prevalence in malnour-
ished people (2.4 %) and a significantly higher preva-
lence in overweight (4.3 %) and obese (7.4 %) subjects
(p = 0.0005).
In the logistic regression, ANOVA, however, the asso-
ciation between BMI and DM was no longer significant
after adjustment for age and WC. Only blood pressure
Table 2 Trends of risk factors in the study population
Baseline (n = 2.062) Follow-up (n = 2.062) Difference p
Period (months) 0 24 (24 to 24) +24
Age (years) 31.0 (20.0 to 46.0) 33.0 (22.0 to 48.0) +2.0 years <0.0001
BMI (Kg/m2) 21.7 (20.1 to 23.5) 22.3 (20.8 to 24.2) +0.6 Kg/m2 <0.0001
WC (cm) 77.0 (72.0 to 83.0) 79.0 (74.0 to 85.0) +2.0 cm <0.0001
SBP (mmHg) 112.5 (102.5 to 124.0) 114.0 (104.5 to 125.0) +1.5 mmHg <0.0001
DBP (mmHg) 72.5 (66.0 to 79.0) 73.5 (67.0 to 80.5) +1.0 mmHg <0.0001
Cardiovascular risk factors
Overweight (%) 11.0 14.3 +23.0 % <0.0001
Obesity (%) 3.8 4.1 +7.8 % 0.53
Abdominal obesity (%) 7.0 10.0 +42.8 % <0.0001
AHT (%) 15.0 20.4 +36.0 % <0.0001
BMI body mass index, WC waist circumference, SBP systolic blood pressure, DBP diastolic blood pressure, AHT arterial hypertension
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(adjusted OR = 1.93; p = 0.01).
Metabolic syndrome
In the entire group, the prevalence of MS was 7.2 %.
The prevalence of MS was higher in the group with
diabetes than in the group without diabetes (40.0 % vs
6.3 %, respectively; p <0.0001) and increased with BMI
from 6.3 % in malnourished to 38.3 % in obese partici-
pants (p <0.0001).
In the logistic regression, multivariate analysis, being
overweight (adjusted OR = 4.1; p = 0.0002) or obese
(adjusted OR = 11.8; p <0.0001) were factors that were
independently associated with MS risk after adjusting
for age, female gender, and DM.
Discussion
This study confirms the relationship between DM and
abdominal obesity but not with general obesity. However,Table 3 Hazard ratio for incidence of Obesity
Number of participants
without obesity at start
number who
developed obesity
Pe
1.842 22 4.
Gender
Male 805 8 1.
Female 1.037 14 2.
Age (years)
< 40 1.203 10 2.
40–59 473 11 1.
≥ 60 166 1 35
Physical activity
Inactivity 136 2 31
Moderate 1.420 19 3.
Intense 286 1 64the prevalence of DM (2.8 %) was low. Similarly, the
prevalence of obesity (9.8 %) and MS (40.0 %) of the group
with DM was low. The study also notes a significant
increase in BMI (+0.6 kg/m2), WC (+2.0 cm), and abdom-
inal obesity (+42.8 %) in this rural population during a
median 24-month follow-up period. This group was also
more overweight (+ 23.0 %), the incidence of obesity was
5.35/1000 person-year and higher in people between the
ages of 40 and 59.
The results of this study are in line with the literature,
which reports a low prevalence of DM in rural areas of
sub-Saharan Africa. Other authors documented the
prevalence of DM at 2.8 % in rural Angola [21] and
2.2 % in rural Nigeria [22]. A low prevalence of DM was
also found in Kaziba (2.9 %), a rural locality within the
same province as this study [10].
In addition, the prevalence of being overweight/obese
was significantly lower in rural areas than in urban areas
of sub-Saharan Africa [10, 23]. This shows that people inrson-year /100.000 Person-year HR (95 % CI) p
105 535 - -
800 444 1
302 608 1.41 (0.59 to 3.35) 0.43
673 374 1
070 1028 2.65 (1.13 to 6.22) 0.02
8 279 0.79 (0.10 to 6.17) 0.83
7 630 1
135 606 1.05 (0.24 to 4.94) 0.94
7 154 0.26 (0.02 to 2.89) 0.27
Table 4 Odd ratio of diabetes mellitus by supposed risk factors
Univariate Model 1 Model 2
Age > 40 years 2.21
(1.44 to 3.38)
- -
High WC 4.09
(2.44 to 6.87)
3.48
(2.04 to 5.93)
-
TG > 150 mg/dl 1.52
(0.79 to 2.91)
- -
AHT 3.26
(2.12 to 5.02)
2.79 (1.76 to 4.41) 1.93
(1.14 to 3.24)
BMI category
Normal 1 1 1
Undernutrition 1.14
(0.45 to 2.90)
1.04
(0.40 to 2.64)
1.06
(0.41 to 2.70)
Overweight 2.17
(1.26 to 3.72)
1.99
(1.14 to 3.46)
1.24
(0.64 to 2.42)
Obesity 3.69
(1.70 to 8.00)
3.17
(1.45 to 6.93)
1.38
(0.52 to 3.66)
Model 1. After adjusted for age
Model 2. After adjusted for age and WC
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itional active lifestyle. However, economic, nutritional,
and epidemiological transitions seems to be faster in
rural areas of developed countries [24] and some North
African regions [25].
Analyses of BMI and WC trends in the study popula-
tion showed both an increase in the prevalence of being
overweight and abdominal obesity during the study
period. The increase in BMI was 0.6 kg/m2 during the
median 2-year follow-up period. This increase is signifi-
cantly higher compared to the global increase in BMI,
which is estimated at 0.4 kg/m2 every 10 years for men
and 0.5 kg/m2 every 10 years for women [26]. This
observation may suggest a rapid increase in “diabesity”
in the near future in this rural area. This would be in
line with the DM global prevalence projection of 98.1 %
in the number of diabetics in Africa by 2030 [2]. In
addition, the urbanization rate is fast on this continent
and will reach 47.7 % in 2030 compared with 39.6 % in
2011 [27].
There was a relatively high prevalence of DM in the
malnourished subgroup compared to subjects with a
normal weight. In addition, the frequency of obesity
(BMI > 30 kg/m2) in the group with DM was very low
(9.8 %). This still confirms the high frequency of atypical
diabetes in this rural area and is consistent with what is
reported in other rural African populations [10, 21, 28].
The mechanisms of this atypical form of DM are not
well-known, but several hypotheses are proposed includ-
ing infection with HHV-8 [29] and hyperferritinemia [30].
Also in this study, the association between DM and BMI
categories disappeared after adjustment for WC. In ad-
dition, only age, abdominal obesity, and AHT remainedassociated with diabetes mellitus risk after adjustment for
all confounders. Thus, the higher age of the malnourished
subjects compared to subjects with normal weight may
account for a relatively high prevalence of DM in mal-
nourished. Further, our observation confirms the major
role of perivisceral fat accumulation in the pathogenesis of
DM in this rural area despite a low prevalence of obesity.
The literature reports an association between DM and
abdominal obesity and not between DM and obesity as
defined by BMI in African rural areas [22]. The under-
lying contributor of “diabesity” may be the insulin resist-
ance of which the best clinical markers are abdominal
obesity and high blood pressure and not obesity defined
by BMI. Theoretically, this observation suggests revising
the definition of “diabesity” and to consider the associ-
ation between diabetes mellitus and abdominal obesity
and not between diabetes mellitus and obesity defined
by BMI. Using this assumption of “diabesity”, 26.9 %,
not 9.8 %, of this study’s cohort would be diabetic. How-
ever, even after this adjustment, the prevalence of
“diabesity” would still be low for this rural area.
The main limitation of this study is the definition of
DM. Being diabetic was based only on fasting blood glu-
cose or taking medication. This may have underestimated
the prevalence of diabetes mellitus. The addition of an oral
glucose tolerance test and/or glycated hemoglobin HbA1c
would have been helpful. In addition, blood glucose and
lipid measurements were only done in the third year of
the study, which does not help to estimate the incidence
of DM and MS.Conclusion
This study reports a low prevalence of diabetes mellitus
and obesity for people living in the rural area of Katana.
The study also shows an association between diabetes
mellitus and abdominal obesity but not with general
obesity. In addition, the rapid increase in abdominal
obesity prevalence in this rural area population within
the follow-up period supports the need for urgent
lifestyle preventive measures in this area.Abbreviations
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